Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: Vaccine makers take aim at an American killer: Seasonal flu

This article was originally published in Scrip

Executive Summary

When the first reports started emerging about a novel H7N9 strain of influenza infecting humans in China, the US licensed vaccine makers – Novartis, GlaxoSmithKline, Sanofi, MedImmune, CSL and Protein Sciences – along with other firms, quickly engaged with American health officials on pursuing a potential product against the virus, which so far has killed about a third of the people it has infected.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC022666

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel